Citadel Advisors - CHECKPOINT THERAPEUTICS INC ownership

CHECKPOINT THERAPEUTICS INC's ticker is CKPT and the CUSIP is 162828107. A total of 69 filers reported holding CHECKPOINT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CHECKPOINT THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$280,000
-21.8%
269,520
-22.5%
0.00%
Q2 2022$358,000
-34.7%
347,792
+12.4%
0.00%
Q1 2022$548,000
-54.1%
309,315
-19.5%
0.00%
Q4 2021$1,194,000
-30.7%
384,223
-26.4%
0.00%
Q3 2021$1,722,000
+34.3%
522,028
+20.1%
0.00%
Q2 2021$1,282,000
+547.5%
434,483
+590.4%
0.00%
Q1 2021$198,000
+350.0%
62,935
+183.3%
0.00%
Q2 2020$44,00022,2120.00%
Other shareholders
CHECKPOINT THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 1,175,832$3,657,0002.24%
PVG ASSET MANAGEMENT CORP 80,307$249,754,0000.91%
EMFO, LLC 196,250$610,0000.54%
Telemetry Investments, L.L.C. 65,000$202,0000.26%
IRONWOOD INVESTMENT MANAGEMENT LLC 136,155$423,0000.21%
Tatro Capital, LLC 18,816$59,0000.04%
Kepos Capital LP 100,000$311,0000.03%
EXANE DERIVATIVES 31,262$97,221,0000.02%
Golden State Equity Partners 13,100$41,0000.02%
Cordant, Inc. 10,820$34,0000.02%
View complete list of CHECKPOINT THERAPEUTICS INC shareholders